The World Health Summit brings together leading researchers, physicians, government officials and representatives from industry, non-governmental organizations (NGOs) and health care systems worldwide.
Among the confirmed speakers are:
(in alphabetical order)
After studying economics he joined Bayer in the Corporate Finance Department. He held several international positions in the company, including member of the Executive Committee and Head of Central Administration & Organization at Bayer HealthCare and Chief Financial Officer of Bayer AG.
An accomplished corneal surgeon and ophthalmologist, Hélène Boisjoly is the first woman to hold the position of Dean of Faculty of Medicine at both the Université de Montréal (UdeM) and in the province of Quebec. She founded and directed the FRSQ Provincial Vision Research Network.
After completing his medical studies in Germany, the specialist for personalized medicine moved to the U.S., where he conducted research at several institutions, among them Massachusetts General Hospital, Harvard Medical School and the National Cancer Institute in Bethesda. He has been the Director of the Biotechnology Center at Albert Einstein College of Medicine in New York, and Director of the Charles Bronfman Institute for Personalized Medicine.
The Professor of infectious diseases and bacteriology used to be Executive Director of the Roll Back Malaria Partnership, served as Director of the UNAIDS Department of Country and Regional Support and was Minister of Health and Prevention of Senegal. She has been awarded numerous professional and academic honours.
Working with the NCD Alliance since its foundation in 2009, her experience includes organisational and strategic development, global advocacy and policy-making, program design and capacity-building in low- and middle-income countries. Before joining the NCD Alliance, she worked at the International Diabetes Federation (IDF) in Brussels, leading their global advocacy program and establishing the first Women and Diabetes program.
Graduated with degrees from the University of the West Indies in Jamaica and the London School of Hygiene & Tropical Medicine, UK, she was Director of Primary Health Care Services, Disaster Coordinator, National Epidemiologist in the Ministry of Health, Coordinator of the National AIDS Program, Chair of the National AIDS Committee, and had two separate terms as Chief Medical Officer. She was the Assistant Director of PAHO, served as the Assistant Director-General of Health Systems and Services at the WHO and was elected PAHO director in September 2012.
A specialist in pharmacology and molecular medicine, Detlev Ganten is one of the world’s top scientists in the field of hypertension. He is the Founding President of the World Health Summit, a former CEO of the Charité – Universitätsmedizin Berlin and Founding Director and CEO of the Max Delbrück Center for Molecular Medicine.
Since 2004, Laurie Garrett has been a senior fellow for global health at the Council on Foreign Relations in New York. Garrett is the only writer ever to have been awarded all three of the Big "Ps" of journalism: the Peabody, the Polk, and the Pulitzer. Her expertise includes global health systems, chronic and infectious diseases, and bioterrorism.
Hermann Gröhe is a certified lawyer who has held a seat in the German Bundestag since 1994. He was a spokesperson for human rights and humanitarian assistance in the Bundestag and acted as legal counsel to the CDU/CSU parliamentary group. Gröhe served one year as a Minister of State to the Federal Chancellor, was the CDU Secretary-General and was appointed Federal Minister of Health in 2013.
An Infectious Disease Epidemiologist and consultant in Public Health Medicine, he used to be the Managing Partner at EpiAfric, worked as co-Director of the Centre for Tuberculosis at the South African National Institute for Communicable Diseases, and was a Consultant Medical Epidemiologist with the UK's Health Protection Agency and at Germany’s Robert Koch Institute. His scientific research has been focused largely on intervention epidemiology.
After holding several positions such as Staff Scientist at the Max Planck Institute for Immunobiology in Freiburg and Chair of the Department of Immunology at the University of Ulm, he became the Founding Director of the Max Planck Institute for Infection Biology in Berlin. The microbiology and immunology expert is a member of the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW) and the German National Academy of Sciences Leopoldina.
As a leading contributor to academic and political debates on governance for health at the national and the global level, she conducts global health diplomacy seminars in many regions and advises the World Health Organization (WHO) at regional and global level. In Switzerland she serves on the executive board of the Careum Foundation and as an advisor for Health 2020.
He is a world renowned kidney disease epidemiologist whose scientific contributions have been in the prevention and epidemiology of kidney disease, hypertension and cardiovascular disease. He led pioneering studies in kidney disease epidemiology, including the first study to assess the incidence of end-stage renal disease and to identify blood pressure as a risk factor for the development of kidney failure.
An anthropologist and expert for infectious disease epidemiology, she previously headed Global Immunisation Communication at UNICEF, chaired GAVI’s Advocacy Task Force, and served on the WHO SAGE Working Group on vaccine hesitancy. Her research focuses on the analysis of social and political factors that can affect uptake of health interventions and influence policies. Her particular interest is on risk and rumor management from clinical trials to delivery – and building public trust.
He joined UNAIDS in 1996 and was appointed Deputy Executive Director of Programme and Assistant Secretary-General of the United Nations in January 2013. He leads UNAIDS’ efforts in leveraging critical support to countries to meet the 2015 global AIDS targets and establish a sustainable response to AIDS. He is a medical doctor with nearly 30 years’ experience in the AIDS response.
After studying history and international law, he entered the Swiss diplomatic service and was appointed ambassador in 2000. In 2010, he was appointed Secretary of State for Foreign Affairs and president of the ICRC in 2012. Under his leadership, the ICRC carries out humanitarian work in over 80 countries.
Professor Peter Piot was the founding Executive Director of UNAIDS and Under Secretary-General of the United Nations from 1995 until 2008, and was an Associate Director of the Global Programme on AIDS of WHO. He was a co-discoverer of the Ebola virus, and his research focused on HIV/AIDS, sexually transmitted infections, and women’s health.
Axel R. Pries is a Professor of Physiology and Dean of the Charité - Universitätsmedizin Berlin. His major research fields are microcirculation, organ perfusion, endothelial function, endothelial surface, vascular adaptation, angiogenesis, tumor microcirculation and blood rheology.
The Global Health expert is an Associate Fellow at the Centre on Global Health Security, Chatham House, a member of the International Advisory Committee for the Global Burden of Disease study, and member of the WHO Euro Advisory Committee on Health Research.
Having spent more than 30 years in public service, his passion for advancing global health began in his native Mali, where he worked to improve the health and welfare of the nomadic Tuareg people. He later became Country Director for Terre des Hommes. He joined UNICEF in the Democratic Republic of the Congo and went on to serve with UNICEF for 14 years, overseeing programs across 10 francophone African countries and serving as country representative.